Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

CMRA

Comera Life Sciences (CMRA)

Comera Life Sciences Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CMRA
DateHeureSourceTitreSymboleSociété
04/01/202414h30GlobeNewswire Inc.Comera Life Sciences Announces Bridge Financing and Exercise of Take Private OptionNASDAQ:CMRAComera Life Sciences Holdings Inc
06/12/202314h30GlobeNewswire Inc.Comera Life Sciences Announces Process Exploring Strategic AlternativesNASDAQ:CMRAComera Life Sciences Holdings Inc
13/11/202314h00GlobeNewswire Inc.Comera Life Sciences Appoints Dorothy Clarke to Board of DirectorsNASDAQ:CMRAComera Life Sciences Holdings Inc
09/11/202314h00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
16/10/202314h00GlobeNewswire Inc.Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
12/09/202314h00GlobeNewswire Inc.Comera Life Sciences Announces the Completion of $4.1 Million Private PlacementNASDAQ:CMRAComera Life Sciences Holdings Inc
16/08/202314h00GlobeNewswire Inc.Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing CapabilitiesNASDAQ:CMRAComera Life Sciences Holdings Inc
10/08/202314h00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
08/08/202314h00GlobeNewswire Inc.Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ PlatformNASDAQ:CMRAComera Life Sciences Holdings Inc
01/08/202314h00GlobeNewswire Inc.Comera Life Sciences Announces $4.1 Million Private PlacementNASDAQ:CMRAComera Life Sciences Holdings Inc
20/07/202314h00GlobeNewswire Inc.Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore ExcipientsNASDAQ:CMRAComera Life Sciences Holdings Inc
11/05/202314h30GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
27/04/202314h00GlobeNewswire Inc.Comera Life Sciences to Participate in Four Upcoming ConferencesNASDAQ:CMRAComera Life Sciences Holdings Inc
03/04/202314h30GlobeNewswire Inc.Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient TechnologyNASDAQ:CMRAComera Life Sciences Holdings Inc
16/03/202313h00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
13/02/202319h45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMRAComera Life Sciences Holdings Inc
12/01/202322h15GlobeNewswire Inc.Comera Life Sciences to Present at 22nd Annual PepTalk ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
05/01/202314h00GlobeNewswire Inc.Comera Life Sciences to Present at Upcoming Biotech Showcase Investor ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
04/01/202322h15GlobeNewswire Inc.Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq RulesNASDAQ:CMRAComera Life Sciences Holdings Inc
17/11/202222h05GlobeNewswire Inc.Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
10/11/202214h00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
09/11/202214h00GlobeNewswire Inc.Comera Life Sciences Appoints Janice Marie McCourt as Chief Business OfficerNASDAQ:CMRAComera Life Sciences Holdings Inc
18/10/202214h00GlobeNewswire Inc.Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 StudyNASDAQ:CMRAComera Life Sciences Holdings Inc
04/10/202216h30GlobeNewswire Inc.Comera Life Sciences Expands Woburn OperationsNASDAQ:CMRAComera Life Sciences Holdings Inc
31/08/202222h15GlobeNewswire Inc.Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business SolutionsNASDAQ:CMRAComera Life Sciences Holdings Inc
22/06/202214h00Business WireComera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore PlatformNASDAQ:CMRAComera Life Sciences Holdings Inc
16/06/202214h00Business WireComera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial OfficerNASDAQ:CMRAComera Life Sciences Holdings Inc
31/05/202214h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMRAComera Life Sciences Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CMRA